Mahyar Sabripour

Title: Mahyar Sabripour: Innovator in Nucleic Acid Amplification

Introduction

Mahyar Sabripour is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid amplification. With a total of three patents to his name, Sabripour's work focuses on improving treatment options for patients with inflammatory bowel disease.

Latest Patents

Sabripour's latest patents include innovative methods for enriching or amplifying nucleic acids in samples from patients suffering from inflammatory bowel disease. These patents provide methods, systems, and kits for selecting patients for treatment with therapeutic agents based on the presence of genotypes associated with positive therapeutic responses. One of the therapeutic agents mentioned is an inhibitor of TL1A activity or expression, such as an anti-TL1A antibody. Another patent details methods for selecting inflammatory bowel disease subjects for treatment with an anti-TL1A antibody based on polymorphisms.

Career Highlights

Throughout his career, Mahyar Sabripour has worked with prominent organizations such as Prometheus Biosciences, Inc. and Cedars-Sinai Medical Center. His experience in these institutions has allowed him to develop and refine his innovative approaches to medical treatment.

Collaborations

Sabripour has collaborated with notable colleagues, including Laurens Kruidenier and Dalin Li. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Mahyar Sabripour is a distinguished inventor whose work in nucleic acid amplification has the potential to significantly impact the treatment of inflammatory bowel disease. His innovative patents and collaborations highlight his commitment to advancing medical science.